Tower Research Capital LLC TRC Buys 3,365 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tower Research Capital LLC TRC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,849 shares of the healthcare conglomerate’s stock after purchasing an additional 3,365 shares during the period. UnitedHealth Group accounts for about 0.6% of Tower Research Capital LLC TRC’s holdings, making the stock its 22nd largest holding. Tower Research Capital LLC TRC’s holdings in UnitedHealth Group were worth $27,746,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. Thematics Asset Management lifted its position in UnitedHealth Group by 16.1% during the fourth quarter. Thematics Asset Management now owns 10,378 shares of the healthcare conglomerate’s stock valued at $5,250,000 after buying an additional 1,438 shares during the period. Transce3nd LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $270,000. Trajan Wealth LLC boosted its stake in UnitedHealth Group by 13.8% in the 4th quarter. Trajan Wealth LLC now owns 39,047 shares of the healthcare conglomerate’s stock worth $19,752,000 after purchasing an additional 4,747 shares in the last quarter. Seaview Investment Managers LLC lifted its position in UnitedHealth Group by 1.9% in the 4th quarter. Seaview Investment Managers LLC now owns 17,727 shares of the healthcare conglomerate’s stock valued at $8,967,000 after acquiring an additional 331 shares in the last quarter. Finally, Sharpepoint LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $223,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 22.0 %

Shares of NYSE:UNH opened at $456.10 on Friday. UnitedHealth Group Incorporated has a 1 year low of $438.50 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $417.20 billion, a PE ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business has a 50 day simple moving average of $512.95 and a two-hundred day simple moving average of $540.29.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the company posted $6.91 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

Several brokerages have issued reports on UNH. Truist Financial raised their target price on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Twenty-one equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $632.85.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.